MedPath

Body Constitution Classification Based Comprehensive Health Management Intervention on Obese Population

Not Applicable
Completed
Conditions
Overweight
Obesity
Interventions
Behavioral: General Management
Behavioral: Health Management
Other: Placebo
Registration Number
NCT02298426
Lead Sponsor
Hai-Jun Wang
Brief Summary

This study aims to explore the effectiveness of body constitution classification based comprehensive health management intervention on obese population.

Detailed Description

This study aims to explore the effectiveness of body constitution classification based comprehensive health management intervention on obese population, compare the differences in effectiveness between body constitution classification based management vs usual health management, and explore the influence of different food composition on the effectiveness of body constitution classification based comprehensive health management intervention on obese population.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1452
Inclusion Criteria
  • Social characteristics:

    • 20-55 year old,
    • had lived in a city for more than one year,
    • kept a watchful eye on losing weight or bodybuilding,
    • practitioner engaged in non- sensitive sectors.
  • Physiological characteristics:

    • met the obesity diagnostic criteria suggested by "Prevention and control Guidelines for overweight and obesity of Chinese adults in 2006". Subjects with a BMI between 24 to 28 kg/m2 were defined as overweight, while those with a BMI greater than 28kg/m2 were obese.
    • met the constitution classification standards of Traditional Chinese Medicine. According to the constitution questionnaire formulated on the base of the Chinese Medical Association standard "Chinese constitution classification and determination" (ZYYXH/T157-2009), the subjects were divided into phlegm-damp type, qi deficiency type and phlegm stasis block type.
Exclusion Criteria
  • with the following major organic disease,
  • secondary obesity caused by diseases,
  • none of phlegm-damp type, qi deficiency type or phlegm stasis block type,
  • women who were planning to become pregnant, pregnant or lactating.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
health management and placeboPlaceboWe provide large scales of weight management information included recipes according to people's constitution. Information is provide through both face to face meeting and telephones. Materials are also given to participants. Meanwhile, we use placebo to replace the dietary supplement products.
general management and placeboGeneral ManagementWe provide general information about health. Information is provided through telephones and materials. Meanwhile, we use placebo to replace the dietary supplement products.
general management and placeboPlaceboWe provide general information about health. Information is provided through telephones and materials. Meanwhile, we use placebo to replace the dietary supplement products.
general management and productGeneral ManagementWe provide general information about health. Information is provided through telephones and materials. Meanwhile, we use dietary supplement products of "SCHSANDRA PLUS", "YI RUI CAPSULE", "Gest Aid Plus": "INFINITUS®" to help balance the constitution of participants.
health management and placeboHealth ManagementWe provide large scales of weight management information included recipes according to people's constitution. Information is provide through both face to face meeting and telephones. Materials are also given to participants. Meanwhile, we use placebo to replace the dietary supplement products.
health management and productHealth ManagementWe provide large scales of weight management information included recipes according to people's constitution. Information is provide through both face to face meeting and telephones. Materials are also given to participants. Meanwhile, we use dietary supplement products of "SCHSANDRA PLUS", "YI RUI CAPSULE", "Gest Aid Plus": "INFINITUS®" to help balance the constitution of participants.
Primary Outcome Measures
NameTimeMethod
BMIBaseline,1year

We measure the body mass index to examine the effect of weight loss Content 10% effective loss of weight Less than 15% safe loss of weight Ensure 5% loss of weight,Content 10% effective loss of weight,Less than 15% safe loss of weight

Secondary Outcome Measures
NameTimeMethod
Body fat percentageBaseline,1year

We measure the body fat percentage to examine the effect of weight loss on body composition.

Fatty liverBaseline,1year

We examine if the participants suffer fatty liver using the method of ultrasonic.

Trial Locations

Locations (1)

Peking University Health Science Center

🇨🇳

Peking, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath